

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.39357128 |
| 2 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.15165769 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.06216795 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.06216795 |
| 5 | protein retention in ER lumen (GO:0006621) | 4.94341283 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.84651098 |
| 7 | regulation of mitochondrial translation (GO:0070129) | 4.65669069 |
| 8 | signal peptide processing (GO:0006465) | 4.30181444 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.27590689 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.27590689 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.11373828 |
| 12 | protein complex biogenesis (GO:0070271) | 4.05572062 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.93475033 |
| 14 | respiratory electron transport chain (GO:0022904) | 3.91268215 |
| 15 | mitotic nuclear envelope reassembly (GO:0007084) | 3.88943907 |
| 16 | nuclear envelope reassembly (GO:0031468) | 3.88943907 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 3.87771348 |
| 18 | proteasome assembly (GO:0043248) | 3.87117023 |
| 19 | electron transport chain (GO:0022900) | 3.85847817 |
| 20 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.72756845 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.72756446 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.65200454 |
| 23 | oxidative phosphorylation (GO:0006119) | 3.55040658 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.49562370 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.49562370 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 3.49562370 |
| 27 | exocrine pancreas development (GO:0031017) | 3.42352542 |
| 28 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.37956967 |
| 29 | protein targeting to mitochondrion (GO:0006626) | 3.36656926 |
| 30 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.33825038 |
| 31 | cullin deneddylation (GO:0010388) | 3.32434494 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.30941756 |
| 33 | cerebellar Purkinje cell layer development (GO:0021680) | 3.29828382 |
| 34 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.28905476 |
| 35 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.28905476 |
| 36 | protein deneddylation (GO:0000338) | 3.24924238 |
| 37 | establishment of protein localization to mitochondrion (GO:0072655) | 3.22025111 |
| 38 | respiratory chain complex IV assembly (GO:0008535) | 3.21120812 |
| 39 | UTP biosynthetic process (GO:0006228) | 3.18999254 |
| 40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.16972898 |
| 41 | type B pancreatic cell proliferation (GO:0044342) | 3.14901761 |
| 42 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.14273165 |
| 43 | L-phenylalanine catabolic process (GO:0006559) | 3.14007566 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14007566 |
| 45 | heme biosynthetic process (GO:0006783) | 3.12868278 |
| 46 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.12001740 |
| 47 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.10841091 |
| 48 | COPII vesicle coating (GO:0048208) | 3.10452607 |
| 49 | proline biosynthetic process (GO:0006561) | 3.10126108 |
| 50 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.09251198 |
| 51 | ER overload response (GO:0006983) | 3.08821385 |
| 52 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.08200214 |
| 53 | mannosylation (GO:0097502) | 3.07936386 |
| 54 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.06353413 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.06231585 |
| 56 | L-phenylalanine metabolic process (GO:0006558) | 3.06231585 |
| 57 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.05991164 |
| 58 | positive regulation of TOR signaling (GO:0032008) | 3.05282495 |
| 59 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.05066076 |
| 60 | rRNA modification (GO:0000154) | 3.03884463 |
| 61 | establishment of integrated proviral latency (GO:0075713) | 3.03170072 |
| 62 | establishment of viral latency (GO:0019043) | 3.03160061 |
| 63 | iron-sulfur cluster assembly (GO:0016226) | 3.02269078 |
| 64 | metallo-sulfur cluster assembly (GO:0031163) | 3.02269078 |
| 65 | heme metabolic process (GO:0042168) | 3.01980516 |
| 66 | protein localization to mitochondrion (GO:0070585) | 2.98263481 |
| 67 | C-terminal protein lipidation (GO:0006501) | 2.96431571 |
| 68 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.96172637 |
| 69 | negative regulation of ligase activity (GO:0051352) | 2.96172637 |
| 70 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.95605895 |
| 71 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.90511456 |
| 72 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.89442578 |
| 73 | peptide hormone processing (GO:0016486) | 2.89384529 |
| 74 | UV protection (GO:0009650) | 2.87497848 |
| 75 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.87249428 |
| 76 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.85522565 |
| 77 | termination of RNA polymerase III transcription (GO:0006386) | 2.85197613 |
| 78 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.85197613 |
| 79 | UTP metabolic process (GO:0046051) | 2.85054605 |
| 80 | base-excision repair, AP site formation (GO:0006285) | 2.85000103 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.83722172 |
| 82 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.82819192 |
| 83 | positive regulation of nuclease activity (GO:0032075) | 2.81412598 |
| 84 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.78867762 |
| 85 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.78378313 |
| 86 | CTP metabolic process (GO:0046036) | 2.77492890 |
| 87 | CTP biosynthetic process (GO:0006241) | 2.77492890 |
| 88 | aldehyde catabolic process (GO:0046185) | 2.75214298 |
| 89 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.75209517 |
| 90 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74657649 |
| 91 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74657649 |
| 92 | pseudouridine synthesis (GO:0001522) | 2.74514823 |
| 93 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.73558954 |
| 94 | vocalization behavior (GO:0071625) | 2.73204153 |
| 95 | ATP biosynthetic process (GO:0006754) | 2.72777108 |
| 96 | GMP metabolic process (GO:0046037) | 2.71932515 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.71532499 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.71532499 |
| 99 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.71532499 |
| 100 | inner mitochondrial membrane organization (GO:0007007) | 2.71531374 |
| 101 | histone arginine methylation (GO:0034969) | 2.69945764 |
| 102 | response to pheromone (GO:0019236) | 2.69753951 |
| 103 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.67814692 |
| 104 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.67589988 |
| 105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.66668960 |
| 106 | vesicle coating (GO:0006901) | 2.66660224 |
| 107 | synaptic vesicle exocytosis (GO:0016079) | 2.65341667 |
| 108 | ribosomal small subunit assembly (GO:0000028) | 2.64824250 |
| 109 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.64745143 |
| 110 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.64745143 |
| 111 | female mating behavior (GO:0060180) | 2.64114902 |
| 112 | aerobic respiration (GO:0009060) | 2.61826086 |
| 113 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.60250575 |
| 114 | pentose-phosphate shunt (GO:0006098) | 2.59525859 |
| 115 | hydrogen peroxide catabolic process (GO:0042744) | 2.59416658 |
| 116 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.59253159 |
| 117 | peptidyl-arginine methylation (GO:0018216) | 2.58943988 |
| 118 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.57840114 |
| 119 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.57840114 |
| 120 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.57341094 |
| 121 | cellular response to unfolded protein (GO:0034620) | 2.57044710 |
| 122 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.56922037 |
| 123 | intestinal cholesterol absorption (GO:0030299) | 2.55160069 |
| 124 | peptidyl-asparagine modification (GO:0018196) | 2.51105132 |
| 125 | endocrine pancreas development (GO:0031018) | 2.48306127 |
| 126 | cellular response to topologically incorrect protein (GO:0035967) | 2.46613981 |
| 127 | ER-nucleus signaling pathway (GO:0006984) | 2.46336923 |
| 128 | zinc ion transport (GO:0006829) | 2.44930050 |
| 129 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.42216862 |
| 130 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.41869372 |
| 131 | regulation of nuclease activity (GO:0032069) | 2.41859727 |
| 132 | neurotransmitter secretion (GO:0007269) | 2.40201084 |
| 133 | aromatic amino acid family catabolic process (GO:0009074) | 2.38906102 |
| 134 | digestion (GO:0007586) | 2.38899268 |
| 135 | cellular modified amino acid catabolic process (GO:0042219) | 2.38619927 |
| 136 | response to endoplasmic reticulum stress (GO:0034976) | 2.38261095 |
| 137 | protein N-linked glycosylation (GO:0006487) | 2.37090355 |
| 138 | regulation of female receptivity (GO:0045924) | 2.37015395 |
| 139 | GDP-mannose metabolic process (GO:0019673) | 2.36819097 |
| 140 | coenzyme catabolic process (GO:0009109) | 2.36180509 |
| 141 | cell redox homeostasis (GO:0045454) | 2.35425723 |
| 142 | synaptic vesicle maturation (GO:0016188) | 2.34923941 |
| 143 | neuron cell-cell adhesion (GO:0007158) | 2.34516264 |
| 144 | detection of calcium ion (GO:0005513) | 2.32609984 |
| 145 | innervation (GO:0060384) | 2.32559955 |
| 146 | positive regulation of amino acid transport (GO:0051957) | 2.31978784 |
| 147 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.31101415 |
| 148 | oxaloacetate metabolic process (GO:0006107) | 2.30725541 |
| 149 | branched-chain amino acid catabolic process (GO:0009083) | 2.29505100 |
| 150 | cellular ketone body metabolic process (GO:0046950) | 2.28843863 |
| 151 | peptidyl-proline hydroxylation (GO:0019511) | 2.28245688 |
| 152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.27533387 |
| 153 | protein carboxylation (GO:0018214) | 2.27533387 |
| 154 | 4-hydroxyproline metabolic process (GO:0019471) | 2.23757918 |
| 155 | positive regulation of insulin secretion (GO:0032024) | 2.22273364 |
| 156 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.22051706 |
| 157 | GTP biosynthetic process (GO:0006183) | 2.21705757 |
| 158 | short-term memory (GO:0007614) | 2.21696496 |
| 159 | insulin secretion (GO:0030073) | 2.20560972 |
| 160 | cysteine metabolic process (GO:0006534) | 2.20120702 |
| 161 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.19654214 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 2.19539145 |
| 163 | sulfur amino acid catabolic process (GO:0000098) | 2.18994322 |
| 164 | glutamate secretion (GO:0014047) | 2.18960472 |
| 165 | galactose catabolic process (GO:0019388) | 2.18571727 |
| 166 | toxin metabolic process (GO:0009404) | 2.17014424 |
| 167 | short-chain fatty acid metabolic process (GO:0046459) | 2.15695144 |
| 168 | branched-chain amino acid metabolic process (GO:0009081) | 2.15629803 |
| 169 | response to unfolded protein (GO:0006986) | 2.11667385 |
| 170 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.11195664 |
| 171 | transferrin transport (GO:0033572) | 2.10612163 |
| 172 | transcytosis (GO:0045056) | 2.10407120 |
| 173 | fucose metabolic process (GO:0006004) | 2.10124269 |
| 174 | ferric iron transport (GO:0015682) | 2.09154535 |
| 175 | trivalent inorganic cation transport (GO:0072512) | 2.09154535 |
| 176 | valine metabolic process (GO:0006573) | 2.08500469 |
| 177 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.07389890 |
| 178 | locomotory exploration behavior (GO:0035641) | 2.07344675 |
| 179 | regulation of oxidative phosphorylation (GO:0002082) | 2.07341453 |
| 180 | reverse cholesterol transport (GO:0043691) | 2.07109227 |
| 181 | inner ear receptor cell development (GO:0060119) | 2.06987709 |
| 182 | response to topologically incorrect protein (GO:0035966) | 2.06859212 |
| 183 | negative regulation of catecholamine secretion (GO:0033604) | 2.06634866 |
| 184 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.06089373 |
| 185 | neurotransmitter transport (GO:0006836) | 2.06089053 |
| 186 | regulation of glutamate secretion (GO:0014048) | 2.05613631 |
| 187 | regulation of synaptic vesicle transport (GO:1902803) | 2.05511425 |
| 188 | high-density lipoprotein particle remodeling (GO:0034375) | 2.04952132 |
| 189 | bile acid biosynthetic process (GO:0006699) | 2.04093960 |
| 190 | glutamate receptor signaling pathway (GO:0007215) | 2.03984770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.84637447 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.77638073 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.62829472 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.62018221 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.46323000 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.36532730 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.17576763 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.00843646 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.96054736 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89159593 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.87886428 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76826775 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.76408706 |
| 14 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.60877014 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.57046145 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.55078370 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53520693 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.49871408 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.45014982 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.37314885 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.33093679 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31391960 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.30637197 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28335432 |
| 25 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.25520530 |
| 26 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.21758066 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.20353813 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.20244287 |
| 29 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.16320157 |
| 30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15782632 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.15225064 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.12526043 |
| 33 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11946184 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09618128 |
| 35 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.06401687 |
| 36 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05300170 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04621738 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03996578 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.03243507 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97880632 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.97665150 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96833383 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.96190883 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.94554069 |
| 45 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.91170814 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90572472 |
| 47 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88821084 |
| 48 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.88616736 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.85123918 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.83309072 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.83309072 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.83082111 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.80900452 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.80638290 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79935703 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76493163 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72392452 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71334052 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71147618 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69887718 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69173839 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68342651 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63201101 |
| 64 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63132903 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62342561 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.62005740 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61491891 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.59166300 |
| 69 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59156122 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.57208577 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.55778926 |
| 72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.54494020 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54364327 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53642338 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52430921 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51836694 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47951428 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47119349 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46494920 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45405541 |
| 81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43068372 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43068372 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42569383 |
| 84 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.42472442 |
| 85 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41962172 |
| 86 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40413039 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40347265 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38316331 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37997813 |
| 90 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37609029 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37385741 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36071151 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.35832023 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.35683728 |
| 95 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34561039 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34034097 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33825814 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33255943 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32846022 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29153591 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27775890 |
| 102 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27517158 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24785145 |
| 104 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24307831 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24051988 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.23227632 |
| 107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22902886 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22349955 |
| 109 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21689226 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20994281 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18583394 |
| 112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18447017 |
| 113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18337372 |
| 114 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17613906 |
| 115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17181325 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17002939 |
| 117 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.15964482 |
| 118 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15839880 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15291094 |
| 120 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14711639 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14369129 |
| 122 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12810127 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12122047 |
| 124 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11368076 |
| 125 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10062191 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.10023885 |
| 127 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09617874 |
| 128 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08151358 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07400523 |
| 130 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07384208 |
| 131 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07382689 |
| 132 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07233226 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06728927 |
| 134 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06289153 |
| 135 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.05696812 |
| 136 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04882375 |
| 137 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04672590 |
| 138 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04465604 |
| 139 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04137456 |
| 140 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03844193 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02691124 |
| 142 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02664805 |
| 143 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02192583 |
| 144 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01222890 |
| 145 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00450847 |
| 146 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00336722 |
| 147 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00263385 |
| 148 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00249579 |
| 149 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00121692 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99715800 |
| 151 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99402597 |
| 152 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98971413 |
| 153 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98969315 |
| 154 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98759079 |
| 155 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98753800 |
| 156 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98381011 |
| 157 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98179118 |
| 158 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.97875300 |
| 159 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97656256 |
| 160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97582550 |
| 161 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97300917 |
| 162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97164619 |
| 163 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97118320 |
| 164 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.96029818 |
| 165 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95576116 |
| 166 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95561055 |
| 167 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93821563 |
| 168 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93576890 |
| 169 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93330840 |
| 170 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92448588 |
| 171 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91778423 |
| 172 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90511781 |
| 173 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88796448 |
| 174 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88174691 |
| 175 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.87828426 |
| 176 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87588588 |
| 177 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87485773 |
| 178 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86278423 |
| 179 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86230137 |
| 180 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85954698 |
| 181 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85567195 |
| 182 | KDM2B_26808549_Chip-Seq_REH_Human | 0.85326202 |
| 183 | JUN_21703547_ChIP-Seq_K562_Human | 0.85308537 |
| 184 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84030655 |
| 185 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83752231 |
| 186 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83748828 |
| 187 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83087862 |
| 188 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81563274 |
| 189 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.81369408 |
| 190 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80912314 |
| 191 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80698229 |
| 192 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.80582912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010030_abnormal_orbit_morphology | 3.57240451 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.31717009 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 2.89643155 |
| 4 | MP0005365_abnormal_bile_salt | 2.86334779 |
| 5 | MP0003186_abnormal_redox_activity | 2.85359657 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.68687133 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.58571441 |
| 8 | MP0005220_abnormal_exocrine_pancreas | 2.49738226 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.48012003 |
| 10 | MP0004272_abnormal_basement_membrane | 2.43644959 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.41636761 |
| 12 | MP0003195_calcinosis | 2.36576468 |
| 13 | MP0005083_abnormal_biliary_tract | 2.34256050 |
| 14 | MP0004043_abnormal_pH_regulation | 2.33716087 |
| 15 | MP0005171_absent_coat_pigmentation | 2.27486295 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.27424999 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.27331338 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.24117976 |
| 19 | MP0003868_abnormal_feces_composition | 2.23662618 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.20660405 |
| 21 | MP0004147_increased_porphyrin_level | 2.18916168 |
| 22 | MP0005085_abnormal_gallbladder_physiolo | 2.13551346 |
| 23 | MP0003880_abnormal_central_pattern | 2.10055135 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 2.06401429 |
| 25 | MP0005379_endocrine/exocrine_gland_phen | 2.04049120 |
| 26 | MP0000751_myopathy | 2.02029599 |
| 27 | MP0002254_reproductive_system_inflammat | 1.98410155 |
| 28 | MP0001944_abnormal_pancreas_morphology | 1.91984441 |
| 29 | MP0002938_white_spotting | 1.90130034 |
| 30 | MP0009745_abnormal_behavioral_response | 1.89144025 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.88743283 |
| 32 | MP0002822_catalepsy | 1.88239451 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.87355357 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.86672369 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.86297513 |
| 36 | MP0002693_abnormal_pancreas_physiology | 1.82002804 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.79774965 |
| 38 | MP0002837_dystrophic_cardiac_calcinosis | 1.78389864 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.78196523 |
| 40 | MP0005360_urolithiasis | 1.75847325 |
| 41 | MP0004270_analgesia | 1.74175576 |
| 42 | MP0002736_abnormal_nociception_after | 1.72414141 |
| 43 | MP0000566_synostosis | 1.72107925 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.70406487 |
| 45 | MP0002064_seizures | 1.69478320 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.67767110 |
| 47 | MP0009840_abnormal_foam_cell | 1.64566179 |
| 48 | MP0008789_abnormal_olfactory_epithelium | 1.61289054 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.59991401 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.58903960 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.58841225 |
| 52 | MP0003959_abnormal_lean_body | 1.58309339 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.55718607 |
| 54 | MP0005332_abnormal_amino_acid | 1.52631015 |
| 55 | MP0008058_abnormal_DNA_repair | 1.50113662 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49004017 |
| 57 | MP0000358_abnormal_cell_content/ | 1.46573223 |
| 58 | MP0003786_premature_aging | 1.46205624 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.44323339 |
| 60 | MP0001188_hyperpigmentation | 1.42709884 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.41417952 |
| 62 | MP0008932_abnormal_embryonic_tissue | 1.39337159 |
| 63 | MP0001664_abnormal_digestion | 1.38722564 |
| 64 | MP0004133_heterotaxia | 1.38018858 |
| 65 | MP0002877_abnormal_melanocyte_morpholog | 1.37955826 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.37875342 |
| 67 | MP0003136_yellow_coat_color | 1.37363440 |
| 68 | MP0005499_abnormal_olfactory_system | 1.34295737 |
| 69 | MP0005394_taste/olfaction_phenotype | 1.34295737 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.34137302 |
| 71 | MP0005508_abnormal_skeleton_morphology | 1.33470573 |
| 72 | MP0003279_aneurysm | 1.32423160 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.31542900 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.30966564 |
| 75 | MP0006035_abnormal_mitochondrial_morpho | 1.30461099 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.29904016 |
| 77 | MP0001440_abnormal_grooming_behavior | 1.29877510 |
| 78 | MP0003329_amyloid_beta_deposits | 1.28555250 |
| 79 | MP0003122_maternal_imprinting | 1.27583473 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.27528772 |
| 81 | MP0006054_spinal_hemorrhage | 1.26317502 |
| 82 | MP0001243_abnormal_dermal_layer | 1.25979988 |
| 83 | MP0001970_abnormal_pain_threshold | 1.25854804 |
| 84 | MP0005535_abnormal_body_temperature | 1.24617830 |
| 85 | MP0002272_abnormal_nervous_system | 1.22532058 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 1.22352559 |
| 87 | MP0003011_delayed_dark_adaptation | 1.20576677 |
| 88 | MP0009046_muscle_twitch | 1.20449072 |
| 89 | MP0000003_abnormal_adipose_tissue | 1.19783565 |
| 90 | MP0002733_abnormal_thermal_nociception | 1.18810679 |
| 91 | MP0002557_abnormal_social/conspecific_i | 1.18486735 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 1.16873313 |
| 93 | MP0005058_abnormal_lysosome_morphology | 1.16053348 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.14015958 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 1.12751423 |
| 96 | MP0002163_abnormal_gland_morphology | 1.12415409 |
| 97 | MP0001756_abnormal_urination | 1.10597951 |
| 98 | MP0000538_abnormal_urinary_bladder | 1.09814919 |
| 99 | MP0000750_abnormal_muscle_regeneration | 1.08840733 |
| 100 | MP0001764_abnormal_homeostasis | 1.07538160 |
| 101 | MP0001958_emphysema | 1.07382294 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 1.04984030 |
| 103 | MP0003718_maternal_effect | 1.03819323 |
| 104 | MP0001905_abnormal_dopamine_level | 1.02751965 |
| 105 | MP0003879_abnormal_hair_cell | 1.01176755 |
| 106 | MP0003283_abnormal_digestive_organ | 1.00592618 |
| 107 | MP0002060_abnormal_skin_morphology | 1.00010016 |
| 108 | MP0001529_abnormal_vocalization | 0.99889107 |
| 109 | MP0005410_abnormal_fertilization | 0.99382850 |
| 110 | MP0002184_abnormal_innervation | 0.98741398 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.98440679 |
| 112 | MP0002067_abnormal_sensory_capabilities | 0.98231901 |
| 113 | MP0005330_cardiomyopathy | 0.98080459 |
| 114 | MP0000613_abnormal_salivary_gland | 0.97056576 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.96496354 |
| 116 | MP0003953_abnormal_hormone_level | 0.95880210 |
| 117 | MP0003693_abnormal_embryo_hatching | 0.95175600 |
| 118 | MP0004924_abnormal_behavior | 0.95050460 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.95050460 |
| 120 | MP0005448_abnormal_energy_balance | 0.94702546 |
| 121 | MP0005408_hypopigmentation | 0.93499131 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.92668396 |
| 123 | MP0005423_abnormal_somatic_nervous | 0.92083968 |
| 124 | MP0004142_abnormal_muscle_tone | 0.90929069 |
| 125 | MP0005501_abnormal_skin_physiology | 0.90030517 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.89963618 |
| 127 | MP0001502_abnormal_circadian_rhythm | 0.89702712 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.89490516 |
| 129 | MP0005503_abnormal_tendon_morphology | 0.89338203 |
| 130 | MP0001486_abnormal_startle_reflex | 0.88600046 |
| 131 | MP0000049_abnormal_middle_ear | 0.88032815 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.86972016 |
| 133 | MP0000749_muscle_degeneration | 0.86484417 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.86202104 |
| 135 | MP0005551_abnormal_eye_electrophysiolog | 0.85823439 |
| 136 | MP0000604_amyloidosis | 0.85187221 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.83773828 |
| 138 | MP0003252_abnormal_bile_duct | 0.82915170 |
| 139 | MP0003315_abnormal_perineum_morphology | 0.82908462 |
| 140 | MP0000762_abnormal_tongue_morphology | 0.82489730 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.80720209 |
| 142 | MP0005165_increased_susceptibility_to | 0.79987636 |
| 143 | MP0005451_abnormal_body_composition | 0.79402143 |
| 144 | MP0008007_abnormal_cellular_replicative | 0.78721763 |
| 145 | MP0004858_abnormal_nervous_system | 0.78414140 |
| 146 | MP0002896_abnormal_bone_mineralization | 0.78381571 |
| 147 | MP0003172_abnormal_lysosome_physiology | 0.78090809 |
| 148 | MP0001542_abnormal_bone_strength | 0.77821886 |
| 149 | MP0005197_abnormal_uvea_morphology | 0.77762107 |
| 150 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77671987 |
| 151 | MP0005670_abnormal_white_adipose | 0.77622367 |
| 152 | MP0000631_abnormal_neuroendocrine_gland | 0.77593860 |
| 153 | MP0000955_abnormal_spinal_cord | 0.76048110 |
| 154 | MP0002066_abnormal_motor_capabilities/c | 0.75447484 |
| 155 | MP0003942_abnormal_urinary_system | 0.74309800 |
| 156 | MP0003385_abnormal_body_wall | 0.74147950 |
| 157 | MP0000681_abnormal_thyroid_gland | 0.73577181 |
| 158 | MP0002090_abnormal_vision | 0.73173774 |
| 159 | MP0006072_abnormal_retinal_apoptosis | 0.69620841 |
| 160 | MP0003191_abnormal_cellular_cholesterol | 0.68116267 |
| 161 | MP0005623_abnormal_meninges_morphology | 0.67734151 |
| 162 | MP0005193_abnormal_anterior_eye | 0.67468766 |
| 163 | MP0010771_integument_phenotype | 0.64906949 |
| 164 | MP0001661_extended_life_span | 0.64422040 |
| 165 | MP0002177_abnormal_outer_ear | 0.64176460 |
| 166 | MP0004019_abnormal_vitamin_homeostasis | 0.63317436 |
| 167 | MP0001881_abnormal_mammary_gland | 0.63304302 |
| 168 | MP0003137_abnormal_impulse_conducting | 0.63237664 |
| 169 | MP0002234_abnormal_pharynx_morphology | 0.63188045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased CSF lactate (HP:0002490) | 3.74519992 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.69307654 |
| 3 | Ketoacidosis (HP:0001993) | 3.69201599 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.67310347 |
| 5 | Type I transferrin isoform profile (HP:0003642) | 3.57683325 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.54660560 |
| 7 | Hypoglycemic seizures (HP:0002173) | 3.49322709 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.37568264 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.37568264 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 3.27887205 |
| 11 | Focal motor seizures (HP:0011153) | 3.22036796 |
| 12 | Abnormality of the intrinsic pathway (HP:0010989) | 3.21822794 |
| 13 | Hypoglycemic coma (HP:0001325) | 3.19088547 |
| 14 | Ketosis (HP:0001946) | 3.15384181 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.14591227 |
| 16 | Cholecystitis (HP:0001082) | 3.14591227 |
| 17 | Hypokinesia (HP:0002375) | 3.01030378 |
| 18 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.00107049 |
| 19 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.00107049 |
| 20 | Abnormal protein glycosylation (HP:0012346) | 3.00107049 |
| 21 | Abnormal glycosylation (HP:0012345) | 3.00107049 |
| 22 | Symptomatic seizures (HP:0011145) | 2.92792412 |
| 23 | Abnormality of glycolysis (HP:0004366) | 2.90968722 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.87422580 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.82062537 |
| 26 | Prolonged neonatal jaundice (HP:0006579) | 2.81263771 |
| 27 | Visual hallucinations (HP:0002367) | 2.80652838 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.80335262 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.80335262 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 2.80335262 |
| 31 | Lactic acidosis (HP:0003128) | 2.79344836 |
| 32 | Exercise intolerance (HP:0003546) | 2.78235280 |
| 33 | Premature rupture of membranes (HP:0001788) | 2.76566472 |
| 34 | Lipid accumulation in hepatocytes (HP:0006561) | 2.76177808 |
| 35 | Respiratory failure (HP:0002878) | 2.72654351 |
| 36 | Increased serum pyruvate (HP:0003542) | 2.68158443 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.67717125 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.66786401 |
| 39 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61664622 |
| 40 | Agitation (HP:0000713) | 2.60139247 |
| 41 | Abnormal pupillary function (HP:0007686) | 2.60067312 |
| 42 | Hypothermia (HP:0002045) | 2.59356187 |
| 43 | Retinal atrophy (HP:0001105) | 2.58052766 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.57379130 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.47850694 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.47170252 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47170252 |
| 48 | Prolonged partial thromboplastin time (HP:0003645) | 2.46470197 |
| 49 | Increased serum lactate (HP:0002151) | 2.45067754 |
| 50 | Opisthotonus (HP:0002179) | 2.43314480 |
| 51 | Hyperglycinemia (HP:0002154) | 2.40109754 |
| 52 | Increased muscle lipid content (HP:0009058) | 2.38447028 |
| 53 | Fat malabsorption (HP:0002630) | 2.37110391 |
| 54 | Focal seizures (HP:0007359) | 2.36297708 |
| 55 | Type II lissencephaly (HP:0007260) | 2.35164885 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.33925598 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.32994789 |
| 58 | Generalized tonic-clonic seizures (HP:0002069) | 2.32443819 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.30837793 |
| 60 | Hepatic necrosis (HP:0002605) | 2.30113831 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27306492 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.26949409 |
| 63 | Atonic seizures (HP:0010819) | 2.25198221 |
| 64 | Emotional lability (HP:0000712) | 2.24722476 |
| 65 | Cholelithiasis (HP:0001081) | 2.24538428 |
| 66 | Acute encephalopathy (HP:0006846) | 2.24081154 |
| 67 | Absence seizures (HP:0002121) | 2.23803941 |
| 68 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.22823687 |
| 69 | Hyperglycemia (HP:0003074) | 2.22615769 |
| 70 | Degeneration of anterior horn cells (HP:0002398) | 2.22399265 |
| 71 | Abnormality of the anterior horn cell (HP:0006802) | 2.22399265 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.21470445 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.20361482 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20361482 |
| 75 | Broad distal phalanx of finger (HP:0009836) | 2.19964235 |
| 76 | Xanthomatosis (HP:0000991) | 2.19718002 |
| 77 | Late onset (HP:0003584) | 2.18630879 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.16951697 |
| 79 | Microvesicular hepatic steatosis (HP:0001414) | 2.16915957 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.14441884 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13701019 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13701019 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13701019 |
| 84 | Methylmalonic aciduria (HP:0012120) | 2.12913286 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12895148 |
| 86 | Protrusio acetabuli (HP:0003179) | 2.12330073 |
| 87 | Mitochondrial inheritance (HP:0001427) | 2.11598067 |
| 88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10593481 |
| 89 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09066184 |
| 90 | Epileptic encephalopathy (HP:0200134) | 2.08249127 |
| 91 | Status epilepticus (HP:0002133) | 2.07411593 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.06432660 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.03906555 |
| 94 | Joint stiffness (HP:0001387) | 2.03311267 |
| 95 | Beaking of vertebral bodies (HP:0004568) | 2.02417856 |
| 96 | Hypophosphatemic rickets (HP:0004912) | 2.02260835 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.01923066 |
| 98 | Lethargy (HP:0001254) | 2.01572614 |
| 99 | Retinal dysplasia (HP:0007973) | 2.00244893 |
| 100 | Cerebral palsy (HP:0100021) | 1.99202538 |
| 101 | Dialeptic seizures (HP:0011146) | 1.98471179 |
| 102 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98397960 |
| 103 | Poor suck (HP:0002033) | 1.95077480 |
| 104 | Delayed CNS myelination (HP:0002188) | 1.94943339 |
| 105 | CNS demyelination (HP:0007305) | 1.94703650 |
| 106 | Polyphagia (HP:0002591) | 1.94286811 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.93604593 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 1.93604593 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 1.92350139 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 1.92265989 |
| 111 | Microretrognathia (HP:0000308) | 1.91885056 |
| 112 | Anxiety (HP:0000739) | 1.91803612 |
| 113 | Abnormality of dentin (HP:0010299) | 1.90516237 |
| 114 | Progressive macrocephaly (HP:0004481) | 1.90460356 |
| 115 | Hyperventilation (HP:0002883) | 1.89119746 |
| 116 | Severe muscular hypotonia (HP:0006829) | 1.88089686 |
| 117 | Cerebral edema (HP:0002181) | 1.87247494 |
| 118 | Cervical subluxation (HP:0003308) | 1.87216478 |
| 119 | Upper limb muscle weakness (HP:0003484) | 1.87182871 |
| 120 | Rough bone trabeculation (HP:0100670) | 1.87124701 |
| 121 | Hypoalphalipoproteinemia (HP:0003233) | 1.85675228 |
| 122 | Achilles tendon contracture (HP:0001771) | 1.84530221 |
| 123 | Hyperphosphaturia (HP:0003109) | 1.84078971 |
| 124 | Deep venous thrombosis (HP:0002625) | 1.84012908 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.83379689 |
| 126 | Optic disc pallor (HP:0000543) | 1.83039262 |
| 127 | Rhinitis (HP:0012384) | 1.82994491 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 1.82164992 |
| 129 | Generalized aminoaciduria (HP:0002909) | 1.81807939 |
| 130 | Biconcave vertebral bodies (HP:0004586) | 1.81700043 |
| 131 | Trismus (HP:0000211) | 1.80705610 |
| 132 | Steatorrhea (HP:0002570) | 1.80585348 |
| 133 | Type I diabetes mellitus (HP:0100651) | 1.80342663 |
| 134 | Spastic paraparesis (HP:0002313) | 1.79833648 |
| 135 | J-shaped sella turcica (HP:0002680) | 1.79689903 |
| 136 | Short nail (HP:0001799) | 1.78544997 |
| 137 | Restlessness (HP:0000711) | 1.78230065 |
| 138 | Complement deficiency (HP:0004431) | 1.78137629 |
| 139 | Nuclear cataract (HP:0100018) | 1.78132359 |
| 140 | Tubulointerstitial nephritis (HP:0001970) | 1.77697698 |
| 141 | Hypobetalipoproteinemia (HP:0003563) | 1.77588973 |
| 142 | Redundant skin (HP:0001582) | 1.77397338 |
| 143 | Abnormality of dental color (HP:0011073) | 1.77324420 |
| 144 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76917610 |
| 145 | Hypolipoproteinemia (HP:0010981) | 1.76555834 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.75566063 |
| 147 | Gout (HP:0001997) | 1.75492182 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.75400742 |
| 149 | Absent epiphyses (HP:0010577) | 1.75290880 |
| 150 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.75290880 |
| 151 | Protuberant abdomen (HP:0001538) | 1.74719865 |
| 152 | Pancreatitis (HP:0001733) | 1.73611494 |
| 153 | Sensorimotor neuropathy (HP:0007141) | 1.73565242 |
| 154 | Ragged-red muscle fibers (HP:0003200) | 1.73109304 |
| 155 | Hyperlipoproteinemia (HP:0010980) | 1.72536975 |
| 156 | Reticulocytosis (HP:0001923) | 1.72369187 |
| 157 | Diminished movement (HP:0002374) | 1.72162068 |
| 158 | Progressive microcephaly (HP:0000253) | 1.71198523 |
| 159 | Hand muscle atrophy (HP:0009130) | 1.71024036 |
| 160 | Spinal rigidity (HP:0003306) | 1.70874529 |
| 161 | Generalized amyotrophy (HP:0003700) | 1.70599485 |
| 162 | Supranuclear gaze palsy (HP:0000605) | 1.69494609 |
| 163 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.69328604 |
| 164 | Fasciculations (HP:0002380) | 1.69064044 |
| 165 | Myokymia (HP:0002411) | 1.68986267 |
| 166 | Cerebral hypomyelination (HP:0006808) | 1.68560784 |
| 167 | Congenital glaucoma (HP:0001087) | 1.68238142 |
| 168 | Blindness (HP:0000618) | 1.67868105 |
| 169 | Abnormality of complement system (HP:0005339) | 1.67849518 |
| 170 | Testicular atrophy (HP:0000029) | 1.67564199 |
| 171 | Hyperglycinuria (HP:0003108) | 1.67399681 |
| 172 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65545470 |
| 173 | Delusions (HP:0000746) | 1.65407282 |
| 174 | Abnormal eating behavior (HP:0100738) | 1.64976841 |
| 175 | Breech presentation (HP:0001623) | 1.63319372 |
| 176 | Exertional dyspnea (HP:0002875) | 1.62580246 |
| 177 | Distal upper limb amyotrophy (HP:0007149) | 1.60200037 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.60200037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.42285561 |
| 2 | TESK1 | 3.91535392 |
| 3 | NTRK3 | 3.85793972 |
| 4 | TESK2 | 3.43115326 |
| 5 | BCKDK | 3.26736207 |
| 6 | LIMK1 | 2.92858216 |
| 7 | NME1 | 2.91318163 |
| 8 | INSRR | 2.82060851 |
| 9 | CASK | 2.55717049 |
| 10 | EPHA4 | 2.44071300 |
| 11 | BUB1 | 2.38941577 |
| 12 | MAP2K7 | 2.30383979 |
| 13 | FRK | 2.19887104 |
| 14 | AKT3 | 2.18048111 |
| 15 | EPHA2 | 2.13944929 |
| 16 | TAOK3 | 1.96799513 |
| 17 | MAPK15 | 1.95951138 |
| 18 | ARAF | 1.91846836 |
| 19 | FER | 1.87448513 |
| 20 | SCYL2 | 1.86331972 |
| 21 | KDR | 1.85519225 |
| 22 | FES | 1.81268105 |
| 23 | MINK1 | 1.76793617 |
| 24 | MAP4K2 | 1.73765166 |
| 25 | MAP3K4 | 1.72905020 |
| 26 | MAP3K2 | 1.72281378 |
| 27 | CSNK1G3 | 1.70693714 |
| 28 | DAPK2 | 1.62602808 |
| 29 | ABL2 | 1.59362976 |
| 30 | PAK4 | 1.57732597 |
| 31 | MARK1 | 1.55728470 |
| 32 | NTRK1 | 1.55291929 |
| 33 | PRKD3 | 1.54198018 |
| 34 | TLK1 | 1.53677433 |
| 35 | VRK1 | 1.53137092 |
| 36 | MAPKAPK3 | 1.52367269 |
| 37 | MAP3K11 | 1.51510858 |
| 38 | MAP2K4 | 1.47848296 |
| 39 | CAMKK2 | 1.40940413 |
| 40 | PNCK | 1.38580276 |
| 41 | ERN1 | 1.38001965 |
| 42 | CSNK1A1L | 1.27773786 |
| 43 | TAOK2 | 1.25049608 |
| 44 | WNK4 | 1.21283825 |
| 45 | MAP3K9 | 1.17471189 |
| 46 | CSNK1G2 | 1.14851125 |
| 47 | CSNK1G1 | 1.13535520 |
| 48 | NEK1 | 1.12404742 |
| 49 | RIPK4 | 1.11513025 |
| 50 | GRK5 | 1.11477488 |
| 51 | SMG1 | 1.11230460 |
| 52 | PLK2 | 1.09378266 |
| 53 | STK16 | 1.09048405 |
| 54 | BRAF | 1.08199096 |
| 55 | MAP3K12 | 1.06935939 |
| 56 | PRKCG | 1.06686370 |
| 57 | DYRK2 | 1.02745994 |
| 58 | CDK19 | 1.02180131 |
| 59 | MAP3K1 | 1.01993278 |
| 60 | MAPK13 | 1.01955692 |
| 61 | PIK3CG | 1.00762946 |
| 62 | CAMK2A | 1.00353269 |
| 63 | CAMKK1 | 1.00008928 |
| 64 | SRPK1 | 0.99969869 |
| 65 | TNIK | 0.99868258 |
| 66 | CAMK2D | 0.99659604 |
| 67 | PRKCE | 0.98503785 |
| 68 | EPHB2 | 0.98194800 |
| 69 | AURKA | 0.96591788 |
| 70 | BRSK1 | 0.96172781 |
| 71 | CAMK2B | 0.95309146 |
| 72 | IRAK2 | 0.91259229 |
| 73 | EIF2AK3 | 0.90266830 |
| 74 | PTK2B | 0.89964199 |
| 75 | KSR2 | 0.88139898 |
| 76 | CDK8 | 0.87621113 |
| 77 | TAF1 | 0.85516031 |
| 78 | LMTK2 | 0.85426574 |
| 79 | CDK5 | 0.85024651 |
| 80 | EPHA3 | 0.82788267 |
| 81 | CAMK2G | 0.81303962 |
| 82 | DAPK3 | 0.80964146 |
| 83 | MAP2K1 | 0.80918048 |
| 84 | IRAK3 | 0.80411475 |
| 85 | ADRBK1 | 0.79110847 |
| 86 | BMPR2 | 0.78704892 |
| 87 | NUAK1 | 0.76981759 |
| 88 | WNK3 | 0.75734977 |
| 89 | RET | 0.75341891 |
| 90 | ADRBK2 | 0.75191426 |
| 91 | MST1R | 0.73612648 |
| 92 | PDK3 | 0.73374152 |
| 93 | PDK4 | 0.73374152 |
| 94 | NTRK2 | 0.70728784 |
| 95 | CAMK1 | 0.70251010 |
| 96 | EIF2AK1 | 0.69719796 |
| 97 | PDK2 | 0.69548989 |
| 98 | CCNB1 | 0.69514988 |
| 99 | PLK1 | 0.66568665 |
| 100 | ILK | 0.66382047 |
| 101 | MYLK | 0.65484088 |
| 102 | NEK9 | 0.65211229 |
| 103 | PLK3 | 0.64931673 |
| 104 | MAPKAPK5 | 0.63889269 |
| 105 | RAF1 | 0.63074406 |
| 106 | PRKD2 | 0.63039902 |
| 107 | MST4 | 0.61702435 |
| 108 | CDK11A | 0.61030124 |
| 109 | DDR2 | 0.60745783 |
| 110 | PAK3 | 0.59940509 |
| 111 | PAK1 | 0.59512867 |
| 112 | UHMK1 | 0.58625016 |
| 113 | PRKCI | 0.58540269 |
| 114 | CAMK1G | 0.58164243 |
| 115 | KSR1 | 0.56952636 |
| 116 | CDK15 | 0.56875720 |
| 117 | DAPK1 | 0.56805163 |
| 118 | CDK18 | 0.56672314 |
| 119 | ICK | 0.56180530 |
| 120 | NEK6 | 0.54453828 |
| 121 | TRIB3 | 0.54152896 |
| 122 | PIM2 | 0.53630314 |
| 123 | RPS6KA5 | 0.53510531 |
| 124 | SIK1 | 0.53264058 |
| 125 | NME2 | 0.53242814 |
| 126 | AURKB | 0.52602733 |
| 127 | CDK14 | 0.52178725 |
| 128 | DYRK1A | 0.51966582 |
| 129 | RPS6KA2 | 0.50647324 |
| 130 | BMX | 0.50411979 |
| 131 | CDK7 | 0.49281769 |
| 132 | CDC42BPA | 0.47969508 |
| 133 | MET | 0.47643001 |
| 134 | PHKG1 | 0.47214659 |
| 135 | PHKG2 | 0.47214659 |
| 136 | PDPK1 | 0.46915395 |
| 137 | MAP2K2 | 0.45848283 |
| 138 | CSNK2A1 | 0.45737880 |
| 139 | GRK7 | 0.45604586 |
| 140 | PAK6 | 0.45327162 |
| 141 | FLT3 | 0.44521470 |
| 142 | AKT2 | 0.44017982 |
| 143 | HIPK2 | 0.43875187 |
| 144 | DMPK | 0.42878994 |
| 145 | MAP2K6 | 0.42406260 |
| 146 | PRKCA | 0.41755698 |
| 147 | GRK1 | 0.41507422 |
| 148 | PTK2 | 0.40302550 |
| 149 | CHEK2 | 0.39502779 |
| 150 | BMPR1B | 0.38879030 |
| 151 | CSNK2A2 | 0.38561978 |
| 152 | PRKCZ | 0.38549606 |
| 153 | CDC7 | 0.38503000 |
| 154 | ATR | 0.38312328 |
| 155 | LATS2 | 0.37346116 |
| 156 | CSNK1A1 | 0.35592510 |
| 157 | LRRK2 | 0.34966676 |
| 158 | PBK | 0.34946166 |
| 159 | ERBB4 | 0.34748832 |
| 160 | TAOK1 | 0.33454408 |
| 161 | RPS6KA4 | 0.32022822 |
| 162 | PRKD1 | 0.31537833 |
| 163 | TRIM28 | 0.30900349 |
| 164 | TBK1 | 0.30389688 |
| 165 | PINK1 | 0.29290649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.20978630 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.38838900 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.14546370 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.71554982 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.41094032 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.30033440 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23305424 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.11344279 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.08718017 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.08406471 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.06633207 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.04263973 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.01413577 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92741912 |
| 15 | Nicotine addiction_Homo sapiens_hsa05033 | 1.92490730 |
| 16 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92171338 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85845237 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.77586118 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.77404540 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76026261 |
| 21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.75684582 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66114286 |
| 23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.66107480 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60342508 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.58961401 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.58646605 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.56549222 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45689763 |
| 29 | GABAergic synapse_Homo sapiens_hsa04727 | 1.44756975 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42644002 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40884577 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.39395934 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39167516 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37338271 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32901151 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31526222 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29891877 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28316918 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27434594 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24948281 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.24709032 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23462268 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22694710 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22206516 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22059274 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 1.19267810 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17872547 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13630499 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13622994 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12566093 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11287570 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11159380 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10492161 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10148585 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09854684 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08433265 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07600879 |
| 58 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06862475 |
| 59 | Purine metabolism_Homo sapiens_hsa00230 | 1.06483895 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 1.06217019 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04284786 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97303803 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.96252186 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96012612 |
| 65 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94189582 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93732721 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93485489 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93120201 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91099307 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90892540 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.89742085 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88487966 |
| 73 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86971032 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86465673 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86044082 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83629181 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80937461 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80374698 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80282158 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.80248626 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80013142 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79618028 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.78692642 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78011654 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77475996 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.76009350 |
| 87 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75233347 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.74610594 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74431844 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73087336 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.72337375 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72061922 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71651591 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.71145762 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70170543 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68856457 |
| 97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67293483 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.66746009 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.66303432 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65862928 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65802373 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65426218 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64449812 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64003842 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62923833 |
| 106 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62481882 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61396880 |
| 108 | Bile secretion_Homo sapiens_hsa04976 | 0.61048254 |
| 109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60994578 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60248947 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60152103 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.59934121 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59648452 |
| 114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59493316 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59235702 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58071202 |
| 117 | RNA transport_Homo sapiens_hsa03013 | 0.57811698 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57798426 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57398480 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54749569 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54495902 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53508753 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53354631 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53295739 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53085961 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51185417 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49876461 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49296710 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49228546 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48032868 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47148627 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46092795 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40593400 |
| 134 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40378465 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39989046 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38919464 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34843142 |
| 138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.26281962 |
| 139 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20596824 |
| 140 | Bladder cancer_Homo sapiens_hsa05219 | 0.20471909 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18891123 |
| 142 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18818048 |
| 143 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.18599293 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.17974979 |

